FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
Haemonetics (NYSE: HAE) reported Q2 EPS of $0.87, $0.18 better than the analyst estimate of $0.69. Revenue for the quarter came in at $253 million versus the consensus estimate of $249.77 million.

